+1-888-308-5802     
News Contact Us

Delays impact Oxford/Astra vaccine production for U.K. supply

Author : Pankaj Singh | Published Date : 2020-11-06 

The United Kingdom is struggling to stock up on supplies of Oxford University/AstraZeneca’s COVID-19 vaccine, a top UK government official has said.

Kate Bingham, UK Vaccine Taskforce chair stated that the aim of 30 million vaccines by September hadn’t been achieved and she anticipated that the UK would get 4 million doses by 2020 instead. The predictions regarding the availability of vaccine doses were made assuming that everything would work smoothly and that there were no interruptions at all, she states.

She said that the scale-up in manufacturing generally took years to do but instead was moving at exceptional speed, adding that the total 100 million vaccine doses would be delivered in the forthcoming year.

Oxford’s clinical trial chief previously stated that he was hopeful that late-stage trial outcomes of its efficacy could be presented by 2020 and those vaccine doses of the shot are already being made.

In May, the UK government inked a deal with Oxford University/AstraZeneca for 100 million doses of the COVID-19, with 30 million doses expected for delivery by Sept. 2020.

The answer to the question of availability COVID-19 vaccine is arguable for now given that no vaccine presently has been approved for use and clinical trials are still ongoing. AstraZeneca said in the statement that the company was making quick progress to start supplying hundreds of millions of COVID-19 doses on a rolling basis once it gets regulatory approval.

But the regulatory challenges cast doubt on how fast the United Kingdom can deploy vaccines, which pivotal in allowing life to return to normal.

Meanwhile, England has commenced its second nationwide lockdown on Thursday, despite a bruising vote the earlier day in which Prime Minster Boris Johnson’s COVID-19 management strategy was not approved by dozens of his MPs.

Source credit- https://in.reuters.com/article/us-health-coronavirus-britain-astrazenec/delivery-timetable-of-oxford-astrazeneca-vaccine-has-slipped-uk-official-says-idINKBN27K2GQ

About Author

Pankaj Singh

Pankaj Singh

Endowed with a post graduate degree in management and finance, Pankaj Singh has been a part of the online content domain for quite a while. Having worked previously as a U.K. insurance underwriter for two years, he now writes articles for fractovia.org and other online portals. He can be contacted at- [email protected] | https://twitter.com/PankajSingh2605

Related News

Facebook fined for USD 6 million for sharing user info in South Korea

Published Date: 2020-11-27         Author: Pankaj Singh

Reportedly, Facebook Inc. was fined for 6.7 billion won (US$6 million) by South Koreas Personal Information Protection Commission (PIPC)for sharing data of around 3.3 million users for business purposes. According to the PIPC, Facebook violated South Koreas personal information law by providing p... Read More

Nestle hands over Yinlu milk, canned porridge businesses to Food Wise

Published Date: 2020-11-26         Author: Pankaj Singh

Nestle has reportedly made an agreement regarding the sale of its China Yinlu peanut milk & canned rice porridge enterprises to Food Wise Co., Limited. The transaction includes all of Yinlu’s operations, comprising its five factories in Sichuan, Fujian, Hubei, and Shandong. The financial t... Read More

No-deal Brexit would cost UK more than COVID-19, warns BoE Governor

Published Date: 2020-11-25         Author: Pankaj Singh

Bank of England Governor, Andrew Bailey, has reportedly warned that the economic cost of a no-deal Brexit would be much more significant in the long haul than the one caused by the COVID-19 pandemic. Bailey stated that failure to finalize a deal prior to the expiration of the Brexit transition by... Read More

© 2020 Fractovia. All Rights Reserved